Your browser doesn't support javascript.
loading
Novel cellular therapies for hepatobiliary malignancies.
Xue, Jing-Nan; Wang, Yan-Yu; Wang, Yun-Chao; Zhang, Nan; Zhang, Long-Hao; Lu, Zheng-Hui; Zhao, Li-Jin; Zhao, Hai-Tao.
Afiliación
  • Xue JN; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
  • Wang YY; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Wang YC; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Zhang N; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Zhang LH; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
  • Lu ZH; Hepatobiliary and Pancreatic Surgery, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen 518000, China.
  • Zhao LJ; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
  • Zhao HT; Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. Electronic address: zhaoht@punch.cn.
Hepatobiliary Pancreat Dis Int ; 21(5): 450-454, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36100543

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Hepatobiliary Pancreat Dis Int Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Límite: Humans Idioma: En Revista: Hepatobiliary Pancreat Dis Int Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China